Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic MSCs for Tibial Diaphyseal Fractures
NCT02140528Phase 2Completed
- Sponsor
- Royan Institute
- Start
- Aug 2013
- Primary completion
- Mar 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CSCC_ASC in tibial fracture, sponsored by Royan Institute. Started Aug 2013; status: completed.
02
Drugs
CSCC_ASC
03
Conditions
tibial fracture
Beyond the preview
Go deeper on NCT02140528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02140528.